IL6 and neoplasm: These results implied that tumor-derived IL-6 exclusively affected the immunosuppressive capacity of tumor CD11b+Gr-1− e-MDSCs, which exerted stronger suppressive effects on T cell immunity than CD11b+Gr-1+ MDSCs.